ASEAN’s Leading Radiopharmaceutical Company
Supporting Future Radiopharmaceutical Access in Malaysia
Cyclotek is engaging with partners in Malaysia to explore how its experience in radiopharmaceutical manufacturing, CDMO support and clinical trial supply could contribute to stronger local and regional capability. Our approach is partnership-led: working with local healthcare, research and industry stakeholders to understand needs, support capability development and improve access to precision diagnostic and therapeutic radiopharmaceuticals over time.
About Us
A Partnership-Led Approach to Regional Capability
Cyclotek brings experience across radiopharmaceutical manufacturing, clinical supply, CDMO support and research translation in Australia and New Zealand. In selected international markets, our approach is to work with local partners, respect local regulatory pathways and support sustainable capability development over time.
Established ANZ radiopharmaceutical manufacturing network
Supporting 200,000+ patient doses annually across Australia and New Zealand
Clinical, research and CDMO capability
Partnership-led regional growth
About Us
Working with local partners to support future capability
Malaysia has an established and growing nuclear medicine community, supported by hospitals, imaging providers and research activity. Cyclotek recognises the opportunity to work with local partners to support future access to specialty PET radiopharmaceuticals, clinical trial capability and radiopharmaceutical development in a way that complements existing local expertise and infrastructure.
Our experienced team works collaboratively with hospitals, researchers and industry partners to deliver innovative radiopharmaceutical solutions that improve diagnosis, treatment and patient outcome.
Products & Services
Capabilities that can support future access
Subject to local regulatory requirements and partnership models, Cyclotek can bring experience across radiopharmaceutical manufacturing, clinical trial support, technology transfer and time-critical supply chain planning.
Product Supply & Logistics
Reliable radiopharmaceutical manufacturing and supply supporting clinical imaging and patient care across Australia and New Zealand.
Contract Manufacturing
Advanced TGA and GMP licensed manufacturing facilities supporting commercial production, research and clinical trial supply.
Local Collaboration
Partnerships before presence
Cyclotek believes meaningful progress starts with strong local partnerships. By working closely with healthcare providers, researchers and industry stakeholders, we aim to understand local needs and explore opportunities to support future capability, patient access and translational innovation.
Partnership & Research
Building Capability Through Partnership
Speak with Cyclotek about partnership opportunities, clinical trial support, CDMO capability or future radiopharmaceutical access in Malaysia.
Partner with Cyclotek
Cyclotek works with healthcare providers, universities, research organisations and pharmaceutical partners to explore pathways that can connect scientific development with reliable manufacturing and patient access.
Insights & Updates
Insights, Research & Industry Updates
National University of Singapore (NUS) Yong Loo Lin School of Medicine – Clinical Imaging Research Centre (CIRC) and Cyclotek Announce Strategic Collaboration to Strengthen Radiopharmaceutical Capability in Singapore and Across ASEAN
Learn More
Showing 3 / 50